Article Detail

Home > Article Detail
  • P-ISSN 1010-0695
  • E-ISSN 2288-3339

Correlations of Subclinical Hypothyroidism with Serum Lipid Profiles and Obesity Index

Journal of Korean Medicine / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2008, v.29 no.3, pp.38-49





  • Downloaded
  • Viewed

Abstract

Objectives:Though overt thyroid dysfunction is well recognized to affect serum lipid profiles and obesity, there are conflicting reports on the effect of subclinical hypothyroidism on serum lipid profiles and obesity. In most reports, the definition of the upper normal limit of serum thyroid stimulation hormone (TSH) of 4.0~5.0mU/L has been used to diagnose. However, recent studies have suggested a much lower TSH cut off with an upper limit of 2.5mU/L, because >95% of rigorously screened normal euthyroid volunteers had serum TSH values between 0.4 and 2.5mU/L. Therefore we defined subclinical hypothyroidism as a TSH level greater than 2.5mU/L. We sought to evaluate the correlations of subclinical hypothyroidism with obesity index and serum lipid profiles Methods:TSH levels were measured in 6190 men and 4223 women that participated in health examination and free T4, lipid profiles (total-cholesterol, triglyceride, LDL-C), and obesity index (body mass index, body fat, waist circumference, C-reactive protein) were also measured. Results:There were significant differences of triglyceride between subclinical hypothyroidism men and normal control subjects. In women, there were also significant differences of triglyceride and LDL-C between subclinical hypothyroidism and normal control subjects. Subclinical hypothyroidism women showed significant correlations of TSH with total cholesterol, LDL-C, triglyceride, and C-reactive protein. Subclinical hypothyroidism men and women with a TSH level 2.5~4.0mU/L had significant differences of triglyceride and body fat. In men, there were significant differences of waist circumference andC-reactive protein. In women, there were significant differences of LDL-C. Conclusions:We have demonstrated correlations of subclinical hypothyroidism with serum lipid profiles and obesity index. These findings suggested that subclinical hypothyroidism people had an increased risk of dyslipidemia and obesity. Subclinical hypothyroidism people with a TSH level 2.5~4.0mU/L may be also considered suspect since it may signal a case of evolving thyroid underactivity eligible to be prevented.

keywords
subclinical hypothyroidism, dyslipidemia, obesity


Reference

1

1. 조정진. 무증상 갑상선 질환. 가정의학회지 2000:21(1):10

2

2. 조용욱. 갑상선 자극 호르몬의 임상적 의의와 정상농도에 대한 소고. 대한내분비학회지 2007; 22(2):87-89

3

3. David S. Cooper. Subclinical hypothyroidism. N Engl J Med. 2001;345(4):260-5

4

4. 이종민, 이광우. 전현성 갑상선 질환의 진단 및 치료. 대한내분비학회지 2002;17(3): 410

5

5. Surks MI. Commentary: Subclinical thyroid dysfunction : A joint statement on manage- ment from the American Association of Clinical Endocrinologists, the American Thyroid Asso- ciation, and The Endocrine Society. J. Clin. Endocrinol. Metab. 2005;90:586-587

6

6. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT. Subclinical Thyroid Dysfunction: A Joint Statement on Management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. J Clin Endocrinol Metab. 2005;90: 581-5;

7

7. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291:228-38

8

8. Medline Medical Encyclopedia.Acessed at http://www.nlm.nih.gov/medlineplus/ency/article/003684.htm

9

9. Watofsky L, Dicky RA. The evidence for a narrower thyrotropin reference range. J Clin Endocrinol Metab. 2005 Sep;90(9):5483-8

10

10. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F. The incidence of thyroid disorders in the community : a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995;43:55–68

11

11. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR. Guidelines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003; 13(1):3-126

12

12. Haugen B. When isn't the TSH Normal and Why? Clinical Implications and Causes. Paper presented at: 12th Annual Meeting of the American Association of Clinical Endocrino- logists(AACE) 2003;SanDiego, Calif

13

13. Vanhaelst L, Neve P, Chailly P, Bastenie PA. Coronary-artery disease in hypothyroidism. Observations in clinical myxoedema. Lancet 1967;2:800-2

14

14. 김경은, 이옥희, 문지현, 이상엽, 김윤진. 무증상 갑상선기능 저하증 환자에서의 혈청 lipopr- otein(a) 및 지질농도 양상. 가정의학회지. 2001; 22(3):345-53

15

15. 최재경, 김종성, 황찬호, 김동현, 황승욱, 조비룡, 허봉렬. 55세 이상 여성에서 무증상 갑상선 기능저하증과 심혈관 요인. 가정의학회지 2002; 22(1):96-103

16

16. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F. The incidence of thyroid disorders in the commun- ity: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol 1995;43: 55–68(462)

17

17. A P Weetman. Fortnightly review: Hypothyr- oidism: screening and subclinical disease. British Medical Jounal 1997;314:1175

18

18. Althaus BU, Staub J-J, Ryff-de Leche A, Oberhansil A, Stahelin HB. LDL/HDL-changes in subclinical hypothyroidism Possible risk factors for coronary heart disease. Clin Endo- crinol 1988;28:157

19

19. Rodondi N, Aujesky D, Vittinghoff E, Cornuz J, Bauer DC. Subclinical hypothyroidism and the risk of coronary heart disease: A meta- analysis. Am J Med. 2006;119:541-551

20

20. Caron Ph, Calazel C, Parra HJ, Hoff M, Louvet JP. Decreased HDL cholesterol in subclinical hypothyroidism: The effect of L- thyroxine therapy. Clin Endocrinol 1990;33:519

21

21. Bogner U, Arnts H-R, Peters H, Schleusener H. Subclinical hypothyroidism and hyperlipo- proteinemia, Indiscriminate L-thyroxine trea- tment not justified. Acta Endocrinol 1993; 128:202

22

22. Staub JJ, Althau BU, Engler H, Ryff AS, Trabucco P, Marquardt K et al. Spectrum of subclinical and overt hypothyroidism Effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 1992;92:633

23

23. 정의주, 김명숙, 정은영, 김종욱, 이근미, 정승필. 건강한 한국성인에서 CRP와 비만지표 및 대사질환 위험도와의 관계. 가정의학회지 2006; 27:620

24

24. Christ-Crain M, Meier C, Guglielmetti M, et al. Elevated C-reactive protein and homocy- steine values: cardiovascular risk factors in hypothyroidism? A cross sectional and a double blind, placebo controlled trial. Atheros- clerosis. 2003;166(2):379-386

25

25. 이상엽, 박혜순, 김선미, 권혁상, 김대영, 김대중, 조금주, 한지혜, 김성래, 박철영, 오승준, 이창범, 김경수, 오상우, 김용성, 최웅환, 유형준. 한국인의 복부비만 기준을 위한 허리둘레 분별점 2006;15(1):7

26

26. 이은정, 이은경, 이유진, 김경원, 최성희, 임수, 박영주, 박도준, 박경수, 장학철, 김성연, 이홍규, 조보연. 65세 이상 노인에서의 무증상 갑상선기능저하 상태와 대사지표의 연관성 분석. 대한 내분비학회 춘계 학술대회 초록집. 2007

27

27. Moulin de Moraes CM, Mancini MC, de Melo ME, Figueiredo DA, Villares SM, Rascovski A, Zilberstein B, Halpern A. Prevalance of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-ex-Y gastric bypass.

28

28. Iacobellis G, Ribaudo MC, Zappatereno A, Iannucci CV, Leonetti F. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponection in euthy- roid obese women. Clin Endocrinol (Oxf). 2005 Apr;62(4):487-91(463)

29

29. Cooper DS, Halpern R,, Wood LC, Levin AA, Ridgway ED. L-thyroxine therapy in subclinical hypothyroidism: a double blind, placebo controlled trial. Ann Intern Med 1984;101: 18-24

30

30. Toft AD, Irvine WJ, Seth J, Cameron EHD. How often should patients be reviewed after treatment with iodine-131 for thyrotoxicosis. BrMed J 1978;2:1115-7

31

31. Hueston WJ. Treatment of hypothyroidism. Am Family Phys. 2001;64:1717-1724.

32

32. Surks MI. Commentary: Subclinical thyroid dysfunction : A joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. J. Clin. Endocrinol. Metab. 2005;90:586-587

33

33. Ringel MD, Mazzaferri EL. Subclinical thyroid dysfunction-Can there be a consensus about the consensus? J. Clin. Endocrinol. Metab. 2005;90:588-590

34

34. 두호경: 동의신계학. 서울: 재단법인 동양의학연구원; 1993, p1056-1065

35

35. 안세영. 갑상선클리닉. 서울: 성보사; 2004, 203-215

36

36. 박지훈, 김호준, 이명종. 준임상적 갑상선기능저하증: 논란이 되는 주제들. 대한한방비만학회지 2006:6(2):30-35

  • Downloaded
  • Viewed
  • 0KCI Citations
  • 0WOS Citations

Other articles from this issue

Recommanded Articles

상단으로 이동

Journal of Korean Medicine